Article Figures & Data
Figures
- Figure 1.
LDL-C Goal Achievement at Week 12
LDL-C=low-density lipoprotein cholesterol.
Reproduced from Stroes E et al. Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients with Statin Intolerance: The GAUSS-2 Randomized, Placebo-controlled Phase 3 Clinical Trial of Evolocumab. J Am Coll Cardiol 2014 doi: 10.1016/j.jacc.2014.03.019. With permission from Elsevier.
Tools
PCSK9 Inhibitor Slashes LDL-C in Statin-Intolerant Patients (GAUSS-2)
Permalink:
Table of contents
Cited By...
- No citing articles found.